GMR Solutions Cuts Expected IPO Price to $15/Share From $22-$25

Dow Jones05-12
 

By Colin Kellaher

 

GMR Solutions, an emergency-medical-services provider backed by private-equity firm KKR, has slashed the expected price of its planned initial public offering.

GMR, also known as Global Medical Response, on Tuesday said it now expects the offering of more than 31.9 million shares will be priced at $15 each, down from a previously expected range of $22 to $25 apiece.

At the $15 offering price, the Lewisville, Texas, company said it expects net proceeds of about $415.2 million, or roughly $483.5 million if the underwriters exercise an option to buy an additional 4.79 million shares.

GMR had previously expected up to $775.5 million in net proceeds.

GMR said it would have about 227.9 million shares outstanding after the IPO, assuming an exercise of the overallotment option and all outstanding warrants, for a market capitalization exceeding $3.4 billion at the $15-a-share pricing.

The company said it has been approved to list its shares on the New York Stock Exchange under the symbol GMRS.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

May 12, 2026 10:38 ET (14:38 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment